IRIS
FERRARO, GIARITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.012
NA - Nord America 3.046
EU - Europa 2.336
SA - Sud America 486
AF - Africa 87
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.987
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.897
SG - Singapore 1.772
RU - Federazione Russa 1.057
CN - Cina 755
IT - Italia 713
VN - Vietnam 699
BR - Brasile 382
HK - Hong Kong 288
FR - Francia 135
DE - Germania 119
BD - Bangladesh 93
IN - India 82
JP - Giappone 79
CA - Canada 65
GB - Regno Unito 55
MX - Messico 53
KR - Corea 50
AR - Argentina 47
FI - Finlandia 42
IE - Irlanda 37
PH - Filippine 29
AT - Austria 26
NL - Olanda 26
TW - Taiwan 22
ES - Italia 21
ZA - Sudafrica 21
CI - Costa d'Avorio 20
SE - Svezia 20
IQ - Iraq 19
PL - Polonia 19
TH - Thailandia 19
ID - Indonesia 14
CO - Colombia 13
EC - Ecuador 13
UA - Ucraina 12
PK - Pakistan 11
TR - Turchia 11
NZ - Nuova Zelanda 9
VE - Venezuela 9
AU - Australia 8
IL - Israele 8
DZ - Algeria 7
EG - Egitto 7
LT - Lituania 7
MA - Marocco 7
PE - Perù 7
CR - Costa Rica 6
PY - Paraguay 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
CH - Svizzera 5
IR - Iran 5
KZ - Kazakistan 5
LB - Libano 5
NP - Nepal 5
SA - Arabia Saudita 5
CL - Cile 4
JM - Giamaica 4
JO - Giordania 4
NG - Nigeria 4
PT - Portogallo 4
RO - Romania 4
AZ - Azerbaigian 3
BB - Barbados 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
GT - Guatemala 3
MY - Malesia 3
NO - Norvegia 3
PR - Porto Rico 3
RS - Serbia 3
SN - Senegal 3
TN - Tunisia 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GD - Grenada 2
GR - Grecia 2
HT - Haiti 2
KE - Kenya 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MT - Malta 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DM - Dominica 1
ET - Etiopia 1
Totale 9.965
Salva come PNG Salva come JPEG
Città #
Singapore 879
San Jose 658
Ashburn 286
Hong Kong 277
Moscow 235
Beijing 201
Hefei 199
Chandler 194
Ho Chi Minh City 191
Naples 157
Hanoi 152
Santa Clara 117
Napoli 114
Lauterbourg 96
Los Angeles 93
The Dalles 68
Tokyo 67
New York 53
São Paulo 53
Millbury 49
Dallas 47
Boston 45
Buffalo 43
Seoul 39
Des Moines 37
Da Nang 34
Council Bluffs 32
Redondo Beach 32
Lawrence 31
Rome 30
Haiphong 29
Nanjing 29
Princeton 29
Munich 27
Milan 24
Chicago 22
Denver 22
Frankfurt am Main 22
Orem 22
Dong Ket 21
Houston 21
Atlanta 19
Falkenstein 19
Mexico City 19
Seattle 19
Wilmington 19
Amsterdam 18
Florence 18
Vienna 17
London 16
Rio de Janeiro 15
Brooklyn 14
Ottawa 14
Toronto 14
Warsaw 14
Biên Hòa 13
Helsinki 13
Chennai 12
Montreal 12
Stockholm 12
Hebei 11
Manchester 10
Mumbai 10
Nanchang 10
Phoenix 10
Thái Nguyên 10
Washington 10
Baghdad 9
Düsseldorf 9
Johannesburg 9
Kochi 9
Shenyang 9
Turku 9
Can Tho 8
Fairfield 8
Guangzhou 8
Miami 8
Miguel Hidalgo 8
Poplar 8
Curitiba 7
Dublin 7
Marigliano 7
New Delhi 7
Padova 7
Salerno 7
San Francisco 7
Hải Dương 6
Jiaxing 6
Pune 6
Querétaro 6
Thái Bình 6
Wuhan 6
Brasília 5
Casablanca 5
Memphis 5
Ninh Bình 5
Parma 5
Poli 5
Porto Alegre 5
Quito 5
Totale 5.372
Salva come PNG Salva come JPEG
Nome #
Label-free quantitative proteomics of the MCF-7 cellular response to a ferritin-metallodrug complex. 204
C-Glycosylation in platinum-based agents: a viable strategy to improve cytotoxicity and selectivity 197
A highly efficient and selective antitumor agent based on a glucoconjugated carbene platinum(ii) complex 167
Analisi minero-petrografiche, chimiche e microbiologiche condotte sulla scultura denominata Real Infante Carlo Tito di Borbone 161
Five-Coordinate Platinum(II) Compounds Containing Sugar Ligands: Synthesis, Characterization, Cytotoxic Activity, and Interaction with Biological Macromolecules 159
A thermophilic C-phycocyanin with unprecedented biophysical and biochemical properties 158
Inside out Porphyridium cruentum: Beyond the Conventional Biorefinery Concept 156
Encapsulation of the Dinuclear Trithiolato-Bridged Arene Ruthenium Complex Diruthenium-1 in an Apoferritin Nanocage: Structure and Cytotoxicity 154
Impact of Hydrophobic Chains in Five-Coordinate Glucoconjugate Pt(II) Anticancer Agents 150
Platinum(II) O,S Complexes Inhibit the Aggregation of Amyloid Model Systems 150
Gold-based drug encapsulation within a ferritin nanocage: X-ray structure and biological evaluation as a potential anticancer agent of the Auoxo3-loaded protein 147
Chloride-free hydrolytic sol–gel synthesis of Nb–P–Si oxides: an approach to solid acid materials 147
A Diruthenium Metallodrug as a Potent Inhibitor of Amyloid-β Aggregation: Synergism of Mechanisms of Action 144
Mapping the protein-binding sites for iridium(III)-based CO-releasing molecules 143
A comparison study on RNase A oligomerization induced by cisplatin, carboplatin and oxaliplatin 141
Five-Coordinate Platinum(II) Compounds as Potential Anticancer Agents 138
Protein-Based Delivery Systems for Anticancer Metallodrugs: Structure and Biological Activity of the Oxaliplatin/β-Lactoglobulin Adduct 137
A new and efficient procedure to load bioactive molecules within the human heavy-chain ferritin nanocage 133
Reaction with Proteins of a Five-Coordinate Platinum(II) Compound 132
The X-ray structure of the primary adducts formed in the reaction between cisplatin and cytochrome c. 131
Cisplatin-Protein Interactions: Unexpected Drug Binding to N-Terminal Amine and Lysine Side Chains 131
Effect of temperature on the interaction of cisplatin with the model protein hen egg white lysozyme 129
Role of the Metal Center in the Modulation of the Aggregation Process of Amyloid Model Systems by Square Planar Complexes Bearing 2-(2'-pyridyl)benzimidazole Ligands 129
Modulation of amyloidogenic peptide aggregation by photoactivatable co-releasing ruthenium(II) complexes 129
Non‐Covalent and Covalent Binding of New Mixed‐Valence Cage‐like Polyoxidovanadate Clusters to Lysozyme 128
Cisplatin binding to human serum albumin: a structural study 128
Preparation, structure, cytotoxicity and mechanism of action of ferritin-Pt(II) terpyridine compound nanocomposites 128
Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor Agents: Minimal Structural Variations and Great Performance Changes 127
Platinated oligomers of bovine pancreatic ribonuclease: Structure and stability. 125
Ferritin nanocages loaded with gold ions induce oxidative stress and apoptosis in MCF-7 human breast cancer cells 123
Cytotoxic properties of a new organometallic platinum(II) complex and its gold(i) heterobimetallic derivatives 121
Deciphering the role of neutral diruthenium complexes in protein binding 119
X-ray Structure of the Carboplatin-Loaded Apo-Ferritin Nanocage 117
Caged noble metals: Encapsulation of a cytotoxic platinum(II)-gold(I) compound within the ferritin nanocage 117
Structural evidences for a secondary gold binding site in the hydrophobic box of lysozyme 116
Structural Characterization of a Gold/Serum Albumin Complex 115
Structural insights and aggregation propensity of a super-stable monellin mutant: A new potential building block for protein-based nanostructured materials 114
Unusual mode of protein binding by a cytotoxic π-arene ruthenium(ii) piano-stool compound containing an O,S-chelating ligand 114
Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent 111
Protein-mediated disproportionation of Au(i): insights from the structures of adducts of Au(iii) compounds bearing N,N-pyridylbenzimidazole derivatives with lysozyme 111
Exchange of Equatorial Ligands in Protein-bound Paddlewheel Ru25+ Complexes: New Insights form X-ray Crystallography and Quantum Chemistry 110
Cisplatin binding to β-lactoglobulin: A structural study 110
The non-swapped monomeric structure of the arginine-binding protein from Thermotoga maritima 109
Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding 109
First Crystal Structure for a Gold Carbene-Protein Adduct 109
Halo complexes of gold(I) containing glycoconjugate carbene ligands: synthesis, characterization, cytotoxicity and interaction with proteins and DNA model systems 106
Ruthenium(II)-Arene Complexes with Glycosylated NHC-Carbene Co-Ligands: Synthesis, Hydrolytic Behavior, and Binding to Biological Molecules 103
Unusual structural features in the adduct of dirhodium tetraacetate with lysozyme 103
Bioactive Molecules Delivery through Ferritin Nanoparticles: Sum Up of Current Loading Methods 100
Arsenoplatin-ferritin nanocage: Structure and cytotoxicity 100
Dirhodium tetraacetate binding to a B-DNA double helical dodecamer probed by X-ray crystallography and mass spectrometry 99
Interaction of Platinum-based Drugs with Proteins: An Overview of Representative Crystallographic Studies 99
Implications of Protein Interaction in the Speciation of Potential VIVO-Pyridinone Drugs 98
Protein-metallodrugs interactions: Effects on the overall protein structure and characterization of Au, Ru and Pt binding sites 96
X-ray structure of C-phycocyanin from Galdieria phlegrea: Determinants of thermostability and comparison with a C-phycocyanin in the entire phycobilisome 95
Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme 93
Interaction of VIVO-8-hydroxyquinoline species with RNase A: the effect of metal ligands in the protein adduct stabilization 93
Evaluation of Auranofin Loading within Ferritin Nanocages 93
On the productive function of furnaces in archaeological sites 93
Unexpected in crystallo reactivity of the potential drug bis(maltolato)oxidovanadium(iv) with lysozyme 91
Biotic and environmental stress induces nitration and changes in structure and function of the sea urchin major yolk protein toposome 90
First Structural Evidence of Binding Modes of Decavanadate to a Protein: Insights from NMR and X-ray Crystallography 90
Binding Modes of Decavanadate to a Protein: first structural Insights from NMR, Mass Spectrometry and X-ray Crystallography 85
Stabilization and Binding of [V4O12]4− and Unprecedented [V20O54(NO3)]n− to Lysozyme upon Loss of Ligands and Oxidation of the Potential Drug VIVO(acetylacetonato)2 82
On the mechanism of action of arsenoplatins: arsenoplatin-1 binding to a B-DNA dodecamer 80
Structural and in Solution Studies on the Interaction of a Vanadium(V) Complex with Lysozyme 75
Exploring the interactions between model proteins and Pd(II) or Pt(II) compounds bearing charged N,N-pyridylbenzimidazole bidentate ligands by X-ray crystallography 74
Ferritin-based anticancer metallodrug delivery: Crystallographic, analytical and cytotoxicity studies 74
Cisplatin Binding to Human Serum Transferrin: A Crystallographic Study 70
Cisplatin Binding Sites in Human H-Chain Ferritin 70
Reactions of a tetranuclear Pt-thiosemicarbazone complex with model proteins 70
Interactions of cisplatin analogues with lysozyme: a comparative analysis 69
Platinum(ii) O,S complexes as potential metallodrugs against Cisplatin resistance 68
Effect of Equatorial Ligand Substitution on the Reactivity with Proteins of Paddlewheel Diruthenium Complexes: Structural Studies 67
Steric hindrance and charge influence on the cytotoxic activity and protein binding properties of diruthenium complexes 67
Ru-Based CO releasing molecules with azole ligands: interaction with proteins and the CO release mechanism disclosed by X-ray crystallography 66
Spectroscopic/Computational Characterization and the X-ray Structure of the Adduct of the VIVO-Picolinato Complex with RNase A 65
Mitochondria Targeting with Luminescent Rhenium(I) Complexes 63
Principles and methods used to grow and optimize crystals of protein-metallodrug adducts, to determine metal binding sites and to assign metal ligands 63
Protein interactions of dirhodium tetraacetate: a structural study 63
The first step of arsenoplatin-1 aggregation in solution unveiled by solving the crystal structure of its protein adduct 63
Metal-based carbon monoxide releasing molecules with promising cytotoxic properties 63
A case of extensive protein platination: The reaction of lysozyme with a Pt(ii)-terpyridine complex 61
Cisplatin binding to angiogenin protein: new molecular pathways and targets for the drug's anticancer activity 60
Charge effect in protein metalation reactions by diruthenium complexes 59
Oxaliplatin inhibits angiogenin proliferative and cell migration effects in prostate cancer cells 57
The NAMI A-human ferritin system: A biophysical characterization 56
Metallodrugs: Mechanisms of Action, Molecular Targets and Biological Activity 54
Reactions with proteins of three novel anticancer platinum(Ii) complexes bearing N-heterocyclic ligands 49
Cisplatin/Apo-Transferrin Adduct: X-ray Structure and Binding to the Transferrin Receptor 1 48
Binding of [VIVO(8-HQ)(H2O)]+ to the model protein lysozyme: structural and computational studies 45
Speciation and structural transformation of a VV–malate complex in the absence and in the presence of a protein: from a dinuclear species to decavanadate 43
V-based drug binding to RNase A 42
Non-covalent Interactions with Proteins of Potential Vanadium Drugs: The Case of the Lysozyme/VIVO-8-hydroxyquinoline adduct 42
Binding to proteins of the pharmacologically active bis(maltolato)oxidovanadium(IV) 38
Interaction of VVO2−hydrazonates with lysozyme 36
Binding to Lysozyme of the Pharmacologically Active VIVO−Pyridinone Drug 36
Binding of oxidovanadium(IV) complexes [VIVO(malt)2] and [VIVO(empp)2] to lysozyme 36
X-ray structures of adducts formed upon reaction of lysozyme with a vanadate complex of 1,2-dimethyl-3-hydroxy-4(1H)-pyridinone 34
Interaction of the pharmacologically active VIVO−Pyridinone drug with the model protein lysozyme 34
Totale 9.897
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.983
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022328 11 0 1 3 9 4 7 23 40 11 88 131
2022/2023465 64 33 18 22 63 53 22 59 69 11 39 12
2023/2024417 20 63 54 33 26 49 11 30 9 22 64 36
2024/20252.436 105 149 46 22 55 110 262 164 207 241 857 218
2025/20265.776 430 391 556 635 964 299 768 327 756 315 179 156
2026/2027134 134 0 0 0 0 0 0 0 0 0 0 0
Totale 10.200